Gabapentin in PTSD: A Retrospective, Clinical Series of Adjunctive Therapy¹

References

• Foa EB, Davidson JRT, Frances A, Culpepper L, Ross R, Ross D (eds): The expert consensus guideline series: Treatment of posttraumatic stress disorder. J Clin Psychiatry 1999; 60\(Suppl. 16):4–76
   Google Scholar
• Brady KT, Pearlstein T, Asnis GM, Barker D, Rothbaum B, Sikes CR, Farfel GM: Efficacy and safety of sertraline treat-ment of posttraumatic stress disorder: A randomized con-trolled trial. JAMA 2000; 283:1831–4844
   Google Scholar
• Connor KM, Sutherland SM, Tupler LA, Malik ML, Davidson JR: Fluoxetine in post-traumatic stress disorder: Randomized, double-blind study. Br J Psychiatry 1999; 175:17–22
   PubMed Web of Science ®Google Scholar
• van der Kolk BA, Drefuss D, Michaels M, Shera D, Berkowitz R, Fisler R, Saxe G: Fluoxetine in posttraumatic stress disor-der. J Clin Psychiatry 1994; 55:517–522
   PubMed Web of Science ®Google Scholar
• Hertzberg MA, Feldman ME, Beckham JC, Kudler HS, Davidson JR: Lack of efficacy for fluoxetine in PTSD: A placebo controlled trial in combat veterans. Ann Clin Psychi-atry 2000; 12:101–105
   PubMedGoogle Scholar
• Friedman MJ, Southwick SM: Towards pharmacotherapy for post-traumatic stress disorder. In: Freidman MJ, Charney DS, Deutch AY, eds. Neurobiological and Clinical Consequences of Stress: From Normal Adaptation to PTSD. Philadelphia: Lippincott-Raven; 1995; 465–81
   Google Scholar
• Keck PE Jr, McElry SL, Friedman LM: Valproate and car-bamazepine in the treatment of panic, posttraumatic stress disorders, withdrawal states, and behavior dyscontrol syn-dromes. J Clin Pyschopharmacol 1992; 12\(Suppl. 1):36S–41S
   Google Scholar
• Hamner MB, Frueh BC, Ulmer HG, Huber MG, Twomey TJ, Tyson C, Arana OW: Psychotic features in chronic posttrau-matic stress disorder and schizophrenia. J Nerv Ment Dis 2000; 1888:217–221
   Google Scholar
• Fesler FA: Valproate in combat-related posttraumatic stress disorder. J Clin Psychiatry 1991; 52:361–364
   PubMed Web of Science ®Google Scholar
• Clark RD, Canive JM, Calais LA, Qualls CR, Tuason VB: Divalproex in posttraumatic stress disorder: An open-label clinical trial. J Trauma Stress 1999; 12:395–401
   PubMed Web of Science ®Google Scholar
• Szymanski 1-TV, Olympia J: Divalproex in posttraumatic stress disorder. Am J Psychiatry 1991; 148:1086–1087
   PubMed Web of Science ®Google Scholar
• Hertzberg MA, Butterfield MI, Feldman ME, Beckham JC, Sutherland SM, Connor KM, Davidson JR: A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol Psychiatry 1999; 45:1226–1229
   PubMed Web of Science ®Google Scholar
• Pande AC, Davidson JRT, Jefferson SW, Janney CA, Katzelnick CA, Weisler RH, Griest JH, Sutherland SM: Treat-ment of social phobia with gabapentin: A placebo-controlled study. J Clin Psychopharm 1999; 19:341–348
   PubMed Web of Science ®Google Scholar
• Crockatt JG, Greiner M, Clift LL, Pande AC: Treatment of panic disorder with gabapentin. NCDEU 1998: Abstract No. 154
   Google Scholar
• Pande AC, Pollack MH, Crockatt MA, Greiner M, Chouinard G, Lydiard RB, Taylor CB, Dager SR, Shiovitz T: Placebo-controlled study of gabapentin treatment of panic disorder. J Clin Psychopharm 2000; 20:467–471
   PubMed Web of Science ®Google Scholar
• Brannon N, Labbate L, Huber M: Gabapentin treatment for posttraumatic stress disorder (letter). Can J Psychiatry 2000; 45:84
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, (DSM-IV), 4th ed. Washington DC: American Psychiatric Association; 1994
   Google Scholar
• Blake D, Weather F, Nagy L, Kaloupek D, Klauminzer G, Charney D, Keane T: A clinician rating scale for assessing current and lifetime PTSD: The CAPS 1. Behav Ther 1990; 18:187–188
   Google Scholar
• Keane Tm, Caddell JM, Taylor KL: Mississippi Scale for Combat-Related Posttraumatic Stress Disorder: Three studies in reliability and validity. J Consult Clin Psychol 1988; 56:85–90
   PubMed Web of Science ®Google Scholar
• Petroff OA, Rothman DL, Bekahr KL, Lamoureux D, Mattson RH: The effect of gabapentin on release of gamma-aminobutyric acid in patients with epilepsy. Ann Neurol 1996; 39:95–99
   PubMed Web of Science ®Google Scholar
• Taylor CP, Gee NS, Su TZ, Kocsis JD, Welty DF, Brown JP, Dooley DJ, Boden P, Singh L: A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res 1998; 29:233–249
   PubMed Web of Science ®Google Scholar
• Morris GL. Gabapentin. Epilepsia 1999; 40\(Supp1.5):S63—S70
   Google Scholar
• Singh L, Field MJ, Ferris P, Hunter JC, Oles RI, Williams RG, Woodruff GN. The antiepileptic gabapentin (neurontin) possesses anxiolytic-like properties and antinociceptive ac-tions that are reversed by d-serine. Psychopharmacology 1996; 127:1–9
   Google Scholar
• Southwick SM, Bremner JD, Rasmusson A, Morgan CA III, Arnsten A, Charney DS: Role of norepinephrine in the patho-physiology and treatment of posttraumatic stress disorder. Biol Psychiatry 1999; 46:1192–1204
   PubMed Web of Science ®Google Scholar
• Hamner MB, Diamond BI, Hitri A: Plasma norepinephrine and MHPG responses to exercise stress in PTSD. In: Murburg MM, ed. Catecholamine Function in Post-Traumatic Stress Disorder: Emerging Concepts. Washington DC: American Psychiatric Press; 1994; 221–232
   Google Scholar
• Mellman TA, Kulick-Bell RL, Kumar A, Nolan B: Sleep and arousal regulation in posttraumatic stress disorder. Sleep Res 1993; 22:153
   Google Scholar